The President's Cancer Panel Wants ... ME?

Article

Exploring ways technology, connectivity and health data can make a difference for cancer patients.

When a Twitter icon indicated I had a new direct message last Tuesday, I took my time opening it. I was down with a bad case of the flu, including a fever and a cough that had stolen my voice, and I wasn’t at the top of my game. However, when I finally clicked on the icon, I felt a jolt of adrenaline.

The message was from “@PresCancerPanel” and started “We’d like to invite you to …”

I leaned forward to double check. I wasn’t hallucinating. The President's Cancer Panel had invited me to participate as a patient advocate in one of their workshops. I almost screamed "YES!", but given my voiceless state, I responded on my iPad as fast as my fingers would permit.

So, I will be flying from Seattle to San Francisco to participate in the President's Cancer Panel workshop on March 26, 2015. The PCP's 2014-15 workshop series Connected Health: Improving Patients’ Engagement and Activation for Cancer-Related Health Outcomes aims "to answer timely, critical questions about connected health strategies and technologies and their potential to engage and activate individuals and patients, with the ultimate goal of improving cancer-related outcomes." Their December 2014 workshop had an impressive list of speakers and participants.

The workshop in which I will be participating is titled, "The Personal Health Data Revolution, Connected Health, and Cancer." It will touch on several topics of interest to me: value of patient networks, ownership of patient-generated data, changing the research process, using electronic health records for the benefit of patients, and privacy and security safeguards. I'm hopeful I will be able to make a valuable contribution to the workshop and make a difference for cancer patients.

I anticipate this workshop will address technology opportunities such as:

  • leveraging patient networks to accelerate cancer research and improve outcomes
  • acknowledging that patients own any data generated as part of their care
  • using devices such as Apple’s new ResearchKit to connect patients to their clinical trials
  • making clinical trial searches easier and more understandable
  • ensuring medical records follow the patient for second opinions and treatment at different facilities

I feel honored, and still a bit stunned, to be a patient voice at this event. If you have any inputs or links to resources you wish me to see before this workshop, please post them in a comment.

Related Videos
Image of a woman with short blonde hair wearing a white blazer.
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.